Profile

Rebecca Glassman, MPH

Senior Public Health Researcher and Data Quality Lead, Pandemic Tracking Collective

Rebecca Glassman has a Master’s in Public Health and is a public health researcher who is committed to social justice and health equity. Her research interests include analyzing COVID data reporting across jurisdictions, health disparities in marginalized communities, and mental health epidemiology. She was a core member of the COVID Tracking Project’s data entry and data quality teams. Prior to her work with The COVID Tracking Project, Rebecca was a research project manager at the University of Florida’s College of Medicine.

Authored Content

  • Apr 05 2022
    Blog Post A User’s Guide to U.S. Vaccine Breakthrough Rates With the United States over a year into its vaccination campaign, all eyes right now are on Covid-19 rates broken out by vaccination status—measures of the number of Covid-19 cases, hospitalizations, and deaths per 100,000 vaccinated or unvaccinated individuals. Shared by the U.S. Centers for Disease Control and Prevention (CDC) as well as many state, […] Dave Luo, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Kaitlyn Johnson, Kara Schechtman, Leo Wolansky, Lindsey Shultz, Rebecca Glassman
  • Dec 22 2021
    Field Note Tracking State Reporting of Covid-19 Vaccine Breakthrough Infections Today, we are releasing a reporting scorecard that evaluates U.S. state data reporting for Covid-19 vaccine breakthrough infections (BI) against best practices we have identified. We assign states letter grades based on their alignment with these best practices for reporting BI data and will update the grades monthly to monitor progress. The scorecard with states’ […] Dave Luo, Jennifer Clyde, Jessica Malaty Rivera, Jonathan Gilmour, Kaitlyn Johnson, Kara Schechtman, Leo Wolansky, Lindsey Shultz, Michal Mart, Rebecca Glassman
  • Dec 01 2021
    Blog Post Genomic Surveillance Is Essential To Track Covid-19 Variants in Both Unvaccinated and Vaccinated Populations Technological advancements have made sequencing quicker and more affordable, but collaboration, outreach, and trust are needed to achieve representative samples from underserved populations. The course of the Covid-19 pandemic depends not only on how the SARS-CoV-2 virus changes, but on how communities respond to it. Public health officials can only make decisions to protect their […] Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
  • Nov 09 2021
    Blog Post The Critical Challenge of Tracking Breakthrough Infections, and Why We Still Need Better Data Standards Despite ample vaccine supplies, outbreaks among unvaccinated populations in the US and the appearance of the Delta variant promote infection in fully vaccinated individuals. These breakthrough infections must be carefully tracked. As the percentage of Americans considered fully vaccinated reached 58 percent, and Covid-19-related deaths surpassed three quarters of a million, concerns over breakthrough infections […] Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
  • Jul 30 2021
    Blog Post Making Sense of Variants: They All Deserve Attention. A Few Merit Concern. SARS-CoV-2 has already mutated since it was first identified and will continue to do so. Robust global genomic sequencing is the best tool for tracking existing variants and detecting new ones. This information enables public health officials, governments, and communities to take action that can save lives. The more high-quality data that is available, the […] Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
Back to Top